...
首页> 外文期刊>European journal of human genetics: EJHG >When knowledge of a heritable gene mutation comes out of the blue: treatment-focused genetic testing in women newly diagnosed with breast cancer
【24h】

When knowledge of a heritable gene mutation comes out of the blue: treatment-focused genetic testing in women newly diagnosed with breast cancer

机译:当可遗传基因突变的知识突然消失时:针对刚诊断出患有乳腺癌的女性进行以治疗为重点的基因检测

获取原文
获取原文并翻译 | 示例
           

摘要

Selection of women for treatment-focused genetic testing (TFGT) following a new diagnosis of breast cancer is changing. Increasingly a patient's age and tumour characteristics rather than only their family history are driving access to TFGT, but little is known about the impact of receiving carrier-positive results in individuals with no family history of cancer. This study assesses the role of knowledge of a family history of cancer on psychosocial adjustment to TFGT in both women with and without mutation carrier-positive results. In-depth semistructured interviews were conducted with 20 women who had undergone TFGT, and who had been purposively sampled to represent women both family history and carrier status, and subjected to a rigorous qualitative analysis. It was found that mutation carriers without a family history reported difficulties in making surgical decisions quickly, while in carriers with a family history, a decision regarding surgery, electing for bilateral mastectomy (BM), had often already been made before receipt of their result. Long-term adjustment to a mutation-positive result was hindered by a sense of isolation not only by those without a family history but also those with a family history who lacked an affected relative with whom they could identify. Women with a family history who had no mutation identified and who had not elected BM reported a lack of closure following TFGT. These findings indicate support deficits hindering adjustment to positive TFGT results for women with and without a family history, particularly in regard to immediate decision-making about risk-reducing surgery.
机译:在对乳腺癌进行新的诊断后,选择用于治疗重点基因检测(TFGT)的女性的方法正在改变。越来越多的患者年龄和肿瘤特征(而不只是其家族史)推动了TFGT的普及,但是对于没有癌症家族史的个体接受载体阳性结果的影响知之甚少。这项研究评估了癌症家族史知识在有和无突变携带者阳性结果的女性中对TFGT进行社会心理调整的作用。进行了半结构化访谈,对20名接受TFGT培训的妇女进行了抽样调查,这些妇女经过抽样抽取以代表妇女的家族史和携带者身份,并进行了严格的定性分析。发现没有家族史的突变携带者报告难以快速做出手术决定,而在有家族史的携带者中,通常在获得结果之前就已经做出了决定手术的选择双侧乳房切除术(BM)的决定。长期对突变阳性结果的调整受到隔离感的阻碍,这不仅是因为没有家族史的人,而且还有那些缺乏亲属身份并可以识别的有家族史的人。有家族病史且未发现突变且未选择BM的妇女报告在TFGT之后没有关闭。这些发现表明,有或没有家族病史的女性,尤其是在有关降低风险手术的即时决策方面,支持不足会阻碍对TFGT阳性结果的调整。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号